The article was written 20 years ago. This shows how complicated p53 is and how valuable Kevetrin can be if it's proven to work in the ovarian cancer trial.
Quote:Good informative article on p53 BUT it did not give anything IMO of how they are solving any p53 problems.
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
